These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 26463326)
1. [Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer]. Chen Y; Peng W; Huang Y; Chen J; Su G; Jiang C; Xiao Y Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):508-11. PubMed ID: 26463326 [TBL] [Abstract][Full Text] [Related]
2. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Jiang ZF; Wang M; Xu JL Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745 [TBL] [Abstract][Full Text] [Related]
3. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients. Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979 [TBL] [Abstract][Full Text] [Related]
4. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer. Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488 [TBL] [Abstract][Full Text] [Related]
5. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer]. Shibayama T; Ohnoshi T; Ueoka H; Horiguchi T; Kodani T; Segawa Y; Maeda T; Miyatake K; Takigawa N; Kimura I Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376 [TBL] [Abstract][Full Text] [Related]
6. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. Dal Bello MG; Filiberti RA; Alama A; Orengo AM; Mussap M; Coco S; Vanni I; Boccardo S; Rijavec E; Genova C; Biello F; Barletta G; Rossi G; Tagliamento M; Maggioni C; Grossi F J Transl Med; 2019 Mar; 17(1):74. PubMed ID: 30849967 [TBL] [Abstract][Full Text] [Related]
7. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer. Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076 [TBL] [Abstract][Full Text] [Related]
8. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. Ma S; Shen L; Qian N; Chen K Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301 [TBL] [Abstract][Full Text] [Related]
9. [Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival]. Załeska M; Szturmowicz M; Zych J; Roszkowska-Sliz B; Demkow U; Langfort R; Roszkowski-Sliz K Pneumonol Alergol Pol; 2010; 78(1):14-20. PubMed ID: 20162514 [TBL] [Abstract][Full Text] [Related]
10. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer. Jiang AG; Chen HL; Lu HY BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656 [TBL] [Abstract][Full Text] [Related]
11. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. Barlési F; Gimenez C; Torre JP; Doddoli C; Mancini J; Greillier L; Roux F; Kleisbauer JP Respir Med; 2004 Apr; 98(4):357-62. PubMed ID: 15080079 [TBL] [Abstract][Full Text] [Related]
13. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer. Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607 [TBL] [Abstract][Full Text] [Related]
14. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay. Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer. Yan P; Han Y; Tong A; Liu J; Wang X; Liu C Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286335 [TBL] [Abstract][Full Text] [Related]
16. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer. Wang H; Zhang X; Liu X; Liu K; Li Y; Xu H J Cancer Res Ther; 2016; 12(1):355-8. PubMed ID: 27072263 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers in the lung cancer diagnosis: a clinical perspective. Li X; Asmitananda T; Gao L; Gai D; Song Z; Zhang Y; Ren H; Yang T; Chen T; Chen M Neoplasma; 2012; 59(5):500-7. PubMed ID: 22668014 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum tumor markers in patients with lung cancer. Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM Respiration; 2002; 69(1):25-9. PubMed ID: 11844959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]